BRILINTA 60 mg/1

BRILINTA 60 mg tablets are a medication used to prevent blood clots. This oral tablet is commonly prescribed for cardiovascular conditions and is manufactured by AstraZeneca Pharmaceuticals LP in the USA.

BRILINTA 60 mg tablets are primarily used to reduce the risk of blood clots in patients with certain heart conditions. This medication is often prescribed for individuals who have experienced a heart attack or have acute coronary syndrome. The active ingredient, ticagrelor, works to inhibit platelet aggregation, which helps to prevent the formation of clots in the blood vessels.

Common effects of BRILINTA 60 mg tablets may include bleeding, bruising, and shortness of breath. Some users might experience dizziness or nausea. It is important to consult a healthcare provider if any of these effects are severe or persistent.

BRILINTA 60 mg tablets should be handled with care, especially if you have a history of bleeding disorders or are undergoing surgery. Always follow the prescribed dosage and inform your healthcare provider about any other medications you are taking. Store the tablets in a cool, dry place away from direct sunlight.

BRILINTA 60 mg tablets may interact with other medications, including blood thinners, NSAIDs, and certain antidepressants. Alcohol consumption should be limited as it can increase the risk of bleeding. Always consult your healthcare provider before starting or stopping any medication.